SHARVIANTY ARIFUDDIN, SHARVIANTY
Unknown Affiliation

Published : 6 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 6 Documents
Search

Ekspresi Phosphatase Regenerating Liver-3 dan E-Cadherin pada Kanker Serviks Stadium Awal dan Lanjut Lokoregional ARIFUDDIN, SHARVIANTY; ASKANDAR, BRAHMANA; MISKAD, UPIK ANDERIANI
Indonesian Journal of Cancer Vol 6, No 3 (2012): Jul - Sep 2012
Publisher : "Dharmais" Cancer Center Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (13.115 KB)

Abstract

Tujuan: untuk menyelidiki hubungan antara ekspresi PRL-3 dan E-Cadherin dengan stadium, jenis histopatologi, dan derajat diferensiasi kanker serviks. Metode: penelitian ini merupakan studi analitik dengan pendekatan potong lintang di beberapa rumah sakit pendidikan Bagian Obstetri dan Ginekologi, Makassar, mulai Januari hingga Juni 2011. Ekspresi PRL-3 dan E-Cadherin diperiksa dengan pengecatan imunohistokimia pada 16 kanker serviks stadium awal dan 15 stadium lanjut lokoregional. Hasil: ekspresi PRL-3 tidak berbeda bermakna antara kanker serviks stadium awal dengan stadium lanjut lokoregional, antara berbagai jenis histopatologik dan derajat diferensiasi (p>0,05). Ekspresi E-Cadherin juga menunjukkan tidak ada perbedaan bermakna antara berbagai stadium, jenis histopatologi, dan derajat diferensiasi (p>0,05). Tidak didapatkan korelasi bermakna antara ekspresi PRL-3 dengan E-Cadherin pada penelitian ini. Kesimpulan: tidak ada hubungan antara ekspresi PRL-3 dan E-Cadherin dengan stadium, jenis histopatologi, dan derajat diferensiasi kanker serviks.Kata Kunci: Kanker serviks stadium awal, kanker serviks stadium lanjutlokoregional, adenokarsinoma, karsinoma sel skuamosa, derajat diferensiasi, PRL-3, E-Cadherin.
The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions Aras, Baharuddin; Tahir, Mardiah; Arifuddin, Sharvianty; Hartono, Eddy; Chalid, Maisuri T.
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 2 April 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (100.621 KB) | DOI: 10.32771/inajog.v6i2.769

Abstract

Objective: Cervical cancer is the second most prevalent cancer inwomen around the world and the most common cancer in womencausing death. This study aims to analyze the connection betweeninfection of human papilloma virus (HPV) 16/18 and cervicalchanges in the acceptors of Depot Medroxyprogesterone Acetate(DMPA) Contraceptions and nonacceptors of Depot MedroxyprogesteroneAcetate (DMPA) Contraceptions.Methods: The research was conducted at the Public ServiceInstitution of Dr. Wahidin Sudirohusodo hospital, and privatemidwife clinics for seven months from December 2015 to June 2016.The research design is cross-sectional with. The samples were fortyacceptors of Depot Medroxyprogesterone Acetate (DMPA) and fortynon-acceptors of Depot Medroxyprogesterone Acetate (DMPA)contraception. Prevalence of HPV 16/18 and cervical cytologychanges were examine using the polymerase chain reaction andliquid base cervical cytology.Results: The results showed there was no significant relationshipbetween long-term use of DMPA contraceptives with HPV 16 and 18.There was no significant relationship between long-term use ofDMPA contraceptives with cervical cytology changes. There was nosignificant relationship between HPV 16 and 18 infections with theoccurrence of cervical cytology changes in long-term use of DMPAcontraceptives.Conclusion: The long-term use of DMPA contraceptive does notincrease the risk of HPV 16 and 18 infections. Also does not causecervical cytology changes that lead to cervical malignancy.Keywords: cervical cytology changes, Depot MedroxyprogesteroneAcetate (DMPA) contraception, HPV 16/18 infection
Endoglin Expression (CD105) in Ephithelial Ovarian Cancer Jumsa, Rizkinov; Rambulangi, John; Arifuddin, Sharvianty; Miskad, Upik
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 2 April 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (107.694 KB) | DOI: 10.32771/inajog.v6i2.801

Abstract

Abstract Objective: Endoglin ( CD105 ) is one of the factors that play a role in vascular development , angiogenesis and vascular homeostasis. The aim of this research is to address the endoglin expression (CD105) in primary tumor and metastasis tumor (omentum) and their relation with clinicopathological factor: stadium, differentiation level, and histological epithelial ovarian cancer. Method: The research was performed at Public Service Hall of Dr. Wahidin Sudirohusodo Hospital and educational networking hospital of Obstetrics and Gynecology Departement of Medical Faculty Hasanuddin University Makassar. The research design is cross sectional with 55 samples consisting of 55 samples of primary tumor and 55 matastasis tumor. Imunohistochemistry examination was performed to all samples. Result:The results show a significant relation between endoglin (CD105) at omentum metastasis tumor and stadium and cell differentiation level of epithelial ovarian cancer. There is no significant relation between endoglin (CD105) expression at primary tumor of ovarian cancer and stadium and differentiation and type of histopathological cell. In addition, there is no significant relation between endoglin expression (CD105) at omentum metastasis tumor and type of histophatological cell of ovarian cancer. There is a significant correlation (strong category) between endoglin expression at omentum metastasis tumor and endoglin expression at primary tumor of epithelial ovarian cancer. Conclusion: Endoglin expression in ovarian cancer metastatic tumor to omentum is correlated to clinical stage and differentiation level of ovarian cancer. And endoglin is one of the pro angiogenic and pro metastasis factors. Keywords:epithelial ovarian cancer, endoglin expression, CD105, immunohistochemistry  
PENGARUH SUPLEMENTASI VITAMIN E TERHADAP KADAR PROSTAGLANDIN (PGF2Α) DAN INTENSITAS NYERI HAID (DYSMENORRHEA) PRIMER PADA REMAJA PUTRI Hutagaol, Iin Octaviana; Arifuddin, Sharvianty; Syamsudin, Saidah
The Southeast Asian Journal of Midwifery Vol 4 No 2 (2018): The Southeast Asian Journal of Midwifery
Publisher : Asosiasi Pendidikan Kebidanan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Painful menstruation (dysmenorrhoe) caused by a primary phase endometrium secretion producing excessive prostaglandin F2 alpha . The research aimed at investigating the effect of vitamin E supplementation on the prostaglandin content (PGF2α) and the primary (dysmenorrhea )intensity. This was a quasi experiment reseacrh with the pre-post test control group design The research result indicates that the average PGF2α content in the intervention group who is given the vitamin E is lower than control group who is given the vitamin E is lower than the control group who is given the placebo. The pain intensity median in the intervention group who is given the vitamin E is lower than the control group who is given the placebo. There is the effect of the vitamin E supplementation on the PGF2a and the pain intesity (dysmenorrhoe). Based on the paired T- test, the PGF2aof the intervention group is (p=0.000) and the cotrol group is (p=0,0.158) with a=0.05. Based on Wilcoxon sign test, the menstrual pain intensity of the intervention group is (p=0.000) and the control group is (p=0.480)..
The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions Aras, Baharuddin; Tahir, Mardiah; Arifuddin, Sharvianty; Hartono, Eddy; Chalid, Maisuri T.
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 2 April 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (100.621 KB) | DOI: 10.32771/inajog.v6i2.769

Abstract

Objective: Cervical cancer is the second most prevalent cancer inwomen around the world and the most common cancer in womencausing death. This study aims to analyze the connection betweeninfection of human papilloma virus (HPV) 16/18 and cervicalchanges in the acceptors of Depot Medroxyprogesterone Acetate(DMPA) Contraceptions and nonacceptors of Depot MedroxyprogesteroneAcetate (DMPA) Contraceptions.Methods: The research was conducted at the Public ServiceInstitution of Dr. Wahidin Sudirohusodo hospital, and privatemidwife clinics for seven months from December 2015 to June 2016.The research design is cross-sectional with. The samples were fortyacceptors of Depot Medroxyprogesterone Acetate (DMPA) and fortynon-acceptors of Depot Medroxyprogesterone Acetate (DMPA)contraception. Prevalence of HPV 16/18 and cervical cytologychanges were examine using the polymerase chain reaction andliquid base cervical cytology.Results: The results showed there was no significant relationshipbetween long-term use of DMPA contraceptives with HPV 16 and 18.There was no significant relationship between long-term use ofDMPA contraceptives with cervical cytology changes. There was nosignificant relationship between HPV 16 and 18 infections with theoccurrence of cervical cytology changes in long-term use of DMPAcontraceptives.Conclusion: The long-term use of DMPA contraceptive does notincrease the risk of HPV 16 and 18 infections. Also does not causecervical cytology changes that lead to cervical malignancy.Keywords: cervical cytology changes, Depot MedroxyprogesteroneAcetate (DMPA) contraception, HPV 16/18 infection
Endoglin Expression (CD105) in Ephithelial Ovarian Cancer Jumsa, Rizkinov; Rambulangi, John; Arifuddin, Sharvianty; Miskad, Upik
Indonesian Journal of Obstetrics and Gynecology Volume 6. No. 2 April 2018
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (107.694 KB) | DOI: 10.32771/inajog.v6i2.801

Abstract

Abstract Objective: Endoglin ( CD105 ) is one of the factors that play a role in vascular development , angiogenesis and vascular homeostasis. The aim of this research is to address the endoglin expression (CD105) in primary tumor and metastasis tumor (omentum) and their relation with clinicopathological factor: stadium, differentiation level, and histological epithelial ovarian cancer. Method: The research was performed at Public Service Hall of Dr. Wahidin Sudirohusodo Hospital and educational networking hospital of Obstetrics and Gynecology Departement of Medical Faculty Hasanuddin University Makassar. The research design is cross sectional with 55 samples consisting of 55 samples of primary tumor and 55 matastasis tumor. Imunohistochemistry examination was performed to all samples. Result:The results show a significant relation between endoglin (CD105) at omentum metastasis tumor and stadium and cell differentiation level of epithelial ovarian cancer. There is no significant relation between endoglin (CD105) expression at primary tumor of ovarian cancer and stadium and differentiation and type of histopathological cell. In addition, there is no significant relation between endoglin expression (CD105) at omentum metastasis tumor and type of histophatological cell of ovarian cancer. There is a significant correlation (strong category) between endoglin expression at omentum metastasis tumor and endoglin expression at primary tumor of epithelial ovarian cancer. Conclusion: Endoglin expression in ovarian cancer metastatic tumor to omentum is correlated to clinical stage and differentiation level of ovarian cancer. And endoglin is one of the pro angiogenic and pro metastasis factors. Keywords:epithelial ovarian cancer, endoglin expression, CD105, immunohistochemistry